| Literature DB >> 34103835 |
Manjula V Ramsali1, Koshy G Puduchira1, Sitaram P Maganti1, Sarada Devi Vankaylapatti2, Surender Pasupuleti2, Dilipkumar Kulkarni2.
Abstract
BACKGROUND AND AIMS: Steven-Johnson Syndrome (SJS) is a rare and severe form of erythema exudative multiforme. Multisystem involvement in SJS and the suspicion of precipitation of the disease with exposure to anesthetic drugs makes anesthesia a challenging task. The concerns during anesthesia are the mucosal lesions and special care that is required to prevent injury to the oropharynx and larynx during airway management and also the drugs used for anesthesia. In the literature, very few isolated case reports or case series are available. Here, we have analyzed the cases of SJS coming for ophthalmic anesthesia, taking into consideration factors like mode of presentation, precipitating factors, associated diseases, types of anesthesia, anesthetic modifications, and various drugs used during anesthesia.Entities:
Keywords: Airway problems; Steven-Johnson Syndrome (SJS); drugs and sensitivity; general anesthesia; ophthalmic surgery; sequel of SJS
Year: 2021 PMID: 34103835 PMCID: PMC8174442 DOI: 10.4103/joacp.JOACP_46_19
Source DB: PubMed Journal: J Anaesthesiol Clin Pharmacol ISSN: 0970-9185
Demographic data
| Number of cases | Percentage of cases | |
|---|---|---|
| Age in yrs | ||
| 9/12-10 | 47 | 9.45% |
| 11-20 | 111 | 22.33% |
| >20 | 339 | 68.21% |
| Sex distribution | ||
| Male | 269 | 54.12% |
| Female | 228 | 45.88% |
Associated disorders
| Associated disorders | Number of cases | Percentage of cases |
|---|---|---|
| Epilepsy | 23 | 4.62% |
| Diabetes | 19 | 3.82% |
| Hypertension | 9 | 1.81% |
| CRF on Haemodialysis | 2 | 0.40% |
| Hypothyroidism on Rx | 2 | 0.40% |
| Koch’s on Rx | 1 | 0.20% |
| Dog bite | 1 | 0.20% |
| Gout | 1 | 0.20% |
| Retroviral sero-positive | 2 | 0.40% |
Precipitating Drugs
| Precipitating drugs | Number of cases | Percentage of cases |
|---|---|---|
| Combination of sulphonamides, phenytoin and NSAIDS | 347 | 69.82 |
| Isolated drugs | ||
| Sulphonamides | 20 | 4.03% |
| Phenytoin | 10 | 2.03% |
| Paracetamol | 2 | 0.40% |
| Chemotheraphy | 1 | 0.20% |
| Vitamin B-complex | 1 | 0.20% |
| Antibiotics | ||
| Ciprofloxacin | 2 | 0.40% |
| Cefotaxime | 1 | 0.20% |
| Amoxicillin | 2 | 0.40% |
| Tetracycline | 1 | 0.20% |
| β lactamases | 2 | 0.40% |
NSAIDs: Nonsteroidal anti-inflammatory drugs
Medication History
| Various drugs | Number of patients | Percentage of cases |
|---|---|---|
| Oral prednisolone | 11 | 2.21% |
| Prednisolone eye drops | 259 | 52.11% |
| Valproate | 3 | 0.62% |
| Levetiracetam | 4 | 0.80% |
| Antihypertensives | 11 | 2.21% |
| Bronchodilators | 54 | 10.86 |
| OHA | 3 | 0.60% |
| Insulin | 1 | 0.20% |
| Tramadol | 15 | 3.02% |
| Clopidogrel/Ecosprin | 11 | 2.21% |
| Cyclosporine | 13 | 2.62% |
| Gabapentin | 1 | 0.20% |
Type of anesthesia
| Type of anesthesia | Number of cases | Percentage of cases |
|---|---|---|
| Local Anesthesia | 56 | 11.3% |
| Lignocaine | 56 | Local anaesthetics were used in combination. |
| Bupivacaine | 56 | |
| Ropivacaine | 54 | |
| General anesthesia | 441 | 88.7% |
| Spontaneous ventilation | 56 | 12.7% |
| Controlled ventilation | 385 | 87.3% |
| LMA | 79 | 11.2% |
| ET intubation | 362 | 72.8% |
LMA: Laryngeal mask airway; ET: Endotracheal
Anesthetic Agents used
| Anesthetic agents | Number of cases | Percentage of cases |
|---|---|---|
| Induction drugs | ||
| Sevoflurane | 259 | 58.7% |
| Propofol | 157 | 35.6% |
| Thiopentone | 25 | 5.6% |
| Muscle relaxants | ||
| Vecuronium | 335 | 76% |
| Atracurium | 106 | 24% |
| Inhalational anesthetics | ||
| Sevoflurane | 284 | 64.5% |
| Isoflurane | 148 | 33.5% |
| Halothane | 9 | 2% |
| Analgesics | ||
| Fentanyl | 239 | 54.2% |
| Tramadol | 78 | 17.7% |
| Butorphanol | 123 | 27.9% |
| Dexmedetomidine | 67 | 15.2% |
Frequency of Anesthetic exposure
| Number of times exposure | Number of patients exposed | Percentage of cases |
|---|---|---|
| 1 | 174 | 35.01% |
| 2 | 61 | 12.27% |
| 3 | 23 | 4.63% |
| 4 | 12 | 2.41% |
| 5 | 6 | 1.21% |
| 6 | 4 | 0.80% |
| 7 | 2 | 0.40% |
| 8 | 2 | 0.40% |